C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 21.1 NOK Market Closed
Market Cap: 1.5B NOK

Relative Value

The Relative Value of one CARA stock under the Base Case scenario is hidden NOK. Compared to the current market price of 21.1 NOK, Carasent ASA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CARA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
41
vs Industry
22
Median 3Y
5.5
Median 5Y
6
Industry
2.3
Forward
5.4
vs History
vs Industry
22
Median 3Y
-24.1
Median 5Y
-42.9
Industry
22.4
Forward
188.1
vs History
17
vs Industry
3
Median 3Y
68.8
Median 5Y
68.8
Industry
14.4
vs History
vs Industry
Median 3Y
-26.2
Median 5Y
-32.3
Industry
21.5
vs History
25
vs Industry
49
Median 3Y
1.4
Median 5Y
1.5
Industry
2.2
vs History
31
vs Industry
25
Median 3Y
3.8
Median 5Y
4.7
Industry
2.5
Forward
4.2
vs History
31
vs Industry
39
Median 3Y
4.6
Median 5Y
5.6
Industry
5.1
vs History
20
vs Industry
6
Median 3Y
40.5
Median 5Y
45.6
Industry
12
Forward
28
vs History
vs Industry
Median 3Y
-30.1
Median 5Y
-12.4
Industry
17.1
Forward
-64.5
vs History
12
vs Industry
4
Median 3Y
44
Median 5Y
46.7
Industry
14.7
vs History
vs Industry
Median 3Y
-16.5
Median 5Y
-16.5
Industry
18.8
vs History
26
vs Industry
42
Median 3Y
1.4
Median 5Y
1.6
Industry
1.8

Multiples Across Competitors

CARA Competitors Multiples
Carasent ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Carasent ASA
OSE:CARA
1.5B NOK 6 -146.9 49.2 -36.5
US
Veeva Systems Inc
NYSE:VEEV
36.7B USD 11.9 42.6 32.3 33.8
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
24.5B AUD 111 212.5 146.9 146.9
JP
M3 Inc
TSE:2413
1.4T JPY 4.6 34.3 17.1 20.4
US
Doximity Inc
NYSE:DOCS
8.2B USD 13.3 32.6 28.5 29.9
US
Waystar Holding Corp
NASDAQ:WAY
5.6B USD 5.4 50.7 16.9 26.4
SE
Sectra AB
STO:SECT B
52.4B SEK 24.6 89.5 -125.8 -125.8
US
Inspire Medical Systems Inc
NYSE:INSP
4B USD 4.5 89.6 74.4 99.9
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
282.4B INR 10.6 58.1 36.2 42.2
US
Vocera Communications Inc
F:V00
2.4B EUR 12 -331.7 271 4 339.1
P/E Multiple
Earnings Growth PEG
NO
C
Carasent ASA
OSE:CARA
Average P/E: 73.7
Negative Multiple: -146.9
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
42.6
32%
1.3
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
212.5
32%
6.6
JP
M3 Inc
TSE:2413
34.3
16%
2.1
US
Doximity Inc
NYSE:DOCS
32.6
18%
1.8
US
W
Waystar Holding Corp
NASDAQ:WAY
50.7
N/A N/A
SE
Sectra AB
STO:SECT B
89.5
28%
3.2
US
Inspire Medical Systems Inc
NYSE:INSP
89.6
13%
6.9
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
58.1
30%
1.9
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -331.7 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NO
C
Carasent ASA
OSE:CARA
Average EV/EBITDA: 69.4
49.2
106%
0.5
US
Veeva Systems Inc
NYSE:VEEV
32.3
39%
0.8
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
146.9
32%
4.6
JP
M3 Inc
TSE:2413
17.1
14%
1.2
US
Doximity Inc
NYSE:DOCS
28.5
23%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
16.9
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -125.8 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
74.4
80%
0.9
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
36.2
24%
1.5
US
V
Vocera Communications Inc
F:V00
271
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NO
C
Carasent ASA
OSE:CARA
Average EV/EBIT: 531.3
Negative Multiple: -36.5
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
33.8
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
146.9
31%
4.7
JP
M3 Inc
TSE:2413
20.4
N/A N/A
US
Doximity Inc
NYSE:DOCS
29.9
25%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
26.4
56%
0.5
SE
Sectra AB
STO:SECT B
Negative Multiple: -125.8 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
99.9
34%
2.9
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
42.2
27%
1.6
US
V
Vocera Communications Inc
F:V00
4 339.1
N/A N/A